Rhode Island H7534 allows licensed pharmacists to prescribe FDA-approved tobacco cessation therapies, subject to state board approval.

Rhode Island H7534 amends existing laws to allow licensed pharmacists to prescribe FDA-approved tobacco cessation drug therapies. This includes implementing the most updated clinical practice guidelines and providing education on medication therapies and cessation strategies. Pharmacists must complete approved tobacco cessation education and refer high-risk patients or those with contraindications to other healthcare providers. Health insurance carriers must cover these services within their provider networks, and Medicaid must also cover tobacco cessation drug therapies.

Rhode Island H7534 allows licensed pharmacists to prescribe FDA-approved tobacco cessation therapies, subject to state board approval.

Rhode Island H7534 amends existing laws to allow licensed pharmacists to prescribe FDA-approved tobacco cessation drug therapies. This includes implementing the most updated clinical practice guidelines and providing education on medication therapies and cessation strategies. Pharmacists must complete approved tobacco cessation education and refer high-risk patients or those with contraindications to other healthcare providers. Health insurance carriers must cover these services within their provider networks, and Medicaid must also cover tobacco cessation drug therapies.